COATED DIBASIC CALCIUM PHOSPHATE
An oral formulation containing an active pharmaceutical ingredient, for instance a peptide pharmaceutical, such as insulin, coated onto a suitable particulate substrate, such as dibasic calcium phosphate. The oral formulation may be a modified release formulation, for instance a controlled release f...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
27.05.2004
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | An oral formulation containing an active pharmaceutical ingredient, for instance a peptide pharmaceutical, such as insulin, coated onto a suitable particulate substrate, such as dibasic calcium phosphate. The oral formulation may be a modified release formulation, for instance a controlled release formulation or a sustained release formulation, or may be an immediate release formulation. Also, the formulation may be encapsulated in gelatin capsules or may be compressed into tablets.
Préparation pour administration per os contenant un principe pharmaceutique actif, par exemple une substance pharmaceutique peptidique telle que l'insuline, appliquée sur un substrat particulaire approprié, du phosphate de calcium dibasique notamment. Cette préparation peut être du type à libération modifiée, contrôlée ou immédiate. De plus, elle peut être intégrée dans des capsules de gélatine ou se présenter sous forme de comprimés. |
---|---|
AbstractList | An oral formulation containing an active pharmaceutical ingredient, for instance a peptide pharmaceutical, such as insulin, coated onto a suitable particulate substrate, such as dibasic calcium phosphate. The oral formulation may be a modified release formulation, for instance a controlled release formulation or a sustained release formulation, or may be an immediate release formulation. Also, the formulation may be encapsulated in gelatin capsules or may be compressed into tablets.
Préparation pour administration per os contenant un principe pharmaceutique actif, par exemple une substance pharmaceutique peptidique telle que l'insuline, appliquée sur un substrat particulaire approprié, du phosphate de calcium dibasique notamment. Cette préparation peut être du type à libération modifiée, contrôlée ou immédiate. De plus, elle peut être intégrée dans des capsules de gélatine ou se présenter sous forme de comprimés. |
Author | RUFF, MICHAEL, D COBB, JOSEPH, E., JR |
Author_xml | – fullname: RUFF, MICHAEL, D – fullname: COBB, JOSEPH, E., JR |
BookMark | eNrjYmDJy89L5WRQcPZ3DHF1UXDxdHIM9nRWcHb0cfYM9VUI8PAPDvAASvEwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvhwfyMDAxMDE2NjUzNHI2PiVAEARiUkVg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | PHOSPHATE DE CALCIUM DIBASIQUE ENROBE |
Edition | 7 |
ExternalDocumentID | WO2004043356A2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2004043356A23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 11:48:04 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2004043356A23 |
Notes | Application Number: WO2003US35075 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040527&DB=EPODOC&CC=WO&NR=2004043356A2 |
ParticipantIDs | epo_espacenet_WO2004043356A2 |
PublicationCentury | 2000 |
PublicationDate | 20040527 |
PublicationDateYYYYMMDD | 2004-05-27 |
PublicationDate_xml | – month: 05 year: 2004 text: 20040527 day: 27 |
PublicationDecade | 2000 |
PublicationYear | 2004 |
RelatedCompanies | METRICS, INC RUFF, MICHAEL, D COBB, JOSEPH, E., JR |
RelatedCompanies_xml | – name: METRICS, INC – name: COBB, JOSEPH, E., JR – name: RUFF, MICHAEL, D |
Score | 2.5928352 |
Snippet | An oral formulation containing an active pharmaceutical ingredient, for instance a peptide pharmaceutical, such as insulin, coated onto a suitable particulate... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | COATED DIBASIC CALCIUM PHOSPHATE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040527&DB=EPODOC&locale=&CC=WO&NR=2004043356A2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt6L9rg9D2rSlFbcUt-nextKmIMgcruK_7yVbdU97Czm4fMBd7pf87gJwW5YISiqn0AvD9HRbIE6Zuf69bpSe4I75IKuISbbFwE3H9tPEmbTgo8mFUXVCf1RxRLSoAu29Vv568X-JFSlu5fKOv2PX52My6kVag44x_DA9LQp7cc4iRjVKEbdpg5eVzLYsxw3QYe9gIO1JAlj8Gsq8lMXmoZIcwm6O-ub1EbTEvAP7tPl7rQN7_fWTNzbX1rc8BkJZgI6GRFkYDDNKaPBMs3Gf5Ckb5imKTuAmiUc01XGo6d_Kpm9sc17WKbQR84szIJZfysDL9bnAEN4ouMnRFivuVlzMLC7OobtN08V28SUcrAgoMh2tC-3661tc4dla82u1Jb_5gngr |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjakDJLWje8VAk2SQkmhc21d5KN9mAILXYiH_f2bTRnnpbdmD2ATP7fbszswC3ZYmkpNILqZAVU9IY8pSZYd1LcmkyqisPvIoYj7ZIjGCsPU30SQc-2lyYpk7oT1McES2qQHuvG3-9-L_EcpvYyuUdfceuz0c_H7piy44Rfiim6DpDL0vdlIiEIG8Tk5eVTFNV3bDRYe8gyLZ4pX3v1eF5KYvNQ8U_gN0M9c3rQ-iweR96pP17rQ978frJG5tr61segUBSGx2N4IaOPQqJQOyIhONYyIJ0lAUoOoYb38tJIOFQ07-VTd_SzXmpJ9BFzs9OQVCtkgMvw6IMIbxcUIWiLVbUqCibqZSdwWCbpvPt4mvoBXkcTaMweb6A_VUwCk9NG0C3_vpml3jO1vSq2Z5fw3h7Gw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COATED+DIBASIC+CALCIUM+PHOSPHATE&rft.inventor=RUFF%2C+MICHAEL%2C+D&rft.inventor=COBB%2C+JOSEPH%2C+E.%2C+JR&rft.date=2004-05-27&rft.externalDBID=A2&rft.externalDocID=WO2004043356A2 |